This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel therapeutic agents. Its structure, featuring a cyclopropyl group and a methoxyphenyl moiety, makes it a valuable intermediate in the creation of compounds targeting the central nervous system. It has been explored for its potential in modulating neurotransmitter systems, which could lead to treatments for neurological and psychiatric disorders such as depression, anxiety, and schizophrenia. Additionally, its unique chemical properties are being investigated for applications in drug discovery programs focused on developing selective receptor agonists or antagonists. Researchers also study its derivatives for their pharmacokinetic and pharmacodynamic profiles to optimize drug efficacy and safety.